Table 3 Multivariable HRs for overall survival.
From: Impact of Diabetes Mellitus on Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy
Variable | HR | 95% CI of HR | P value |
|---|---|---|---|
Age | 1.00 | 0.99–1.01 | 0.93 |
DM | 0.97 | 0.68–1.40 | 0.87 |
Stage* | 0.02 | ||
Stage III | 1.75 | 0.78–3.93 | 0.18 |
Stage IVA | 2.08 | 0.97–4.45 | 0.06 |
Stage IVB | 2.83 | 1.28–6.25 | 0.01 |
RT dose (Gy) | 0.98 | 0.96–0.99 | 0.002 |
Cisplatin dose (mg/m2) | 1.00 | 0.997–1.001 | 0.25 |
Weight loss during CCRT (%) | 0.99 | 0.97–1.002 | 0.09 |
Infection | 1.72 | 1.32–2.24 | 0.001 |
